Grupo NotreDame Intermedica Participações S A : Results Presentations

Earnings Call Presentation

3Q22

CONFERENCE CALL NOVEMBER 10, 2022 | 11am BRT

NEW HOSPITAL - MANDACARU/PE		NEW ADVANCED UNIT - BETIM/MG
Inaugurated in June 2022		Inaugurated in August 2022

Financial

Highlights Solid organic growth with cash MLR improvement

									+122k lives of
Sustainable Growth
								organic net adds
										in 3Q22
		3Q22 vs. 3Q21		9M22 vs. 9M21
					~103%	Adjusted
Net Revenues		R$6,321	+9.4%		R$18,368 +10.6%
(R$ million)			Ebitda	growth
Health Beneficiaries	09/30 | (k)	9,035	+5.0%
Dental Beneficiaries	09/30 | (k)	6,881	+6.6%

Cash MLR			Cash SG&A (% NOR)(1)		Adjusted EBITDA(2)
3Q21 - 74.7%			3Q21 - 15.2%		3Q21 - R$453.9mm
3Q22 - 73.0%			3Q22 - 11.5%		3Q22 - R$922.7mm
	-1.7pp		(18.1% ex Promed Reimbursement)

2021 data represent the combination (simple sum) of Hapvida Participações and NotreDame Intermédica Participações 2022 data includes the month of January for BCBF Participações S.A.

(1) Excluding non-cash expenses with D&A, Stock Options and LTIP	2
(2) Excluding only non-cash expenses with Stock Options and LTIP

Integration

Highlights Firm commitment to capturing synergies

Scheduled

Year 1		Year 2		Year 3
Feb'22 - Jan'23		Feb'23 - Jan'24		Feb'24 - Jan'25

Identification and Scheduling of

Opportunities

Synergies Capture

Organizational Structure Optimization &

Launch of Nosso Plano Integrado

• Access to the largest service network in the country, present in 21 states
• Initially aimed at the corporate market (100+ lives)
• Unique visual identity, with a single card
• One single contract and invoice

Monthly Targets of Recurring EBITDA
form Synergies on Selct Dates	R$mm
	115

Process Unification and Review

Standardization of Indicators &

Technology Journey

Nov'22

• National Solution with 69,000 lives implemented by Sept'22
• Individual Products with 53,000 lives implemented by Sept'22
• New tables for purchasing materials and medicines implemented
• Cross-accreditation:verticalization through network sharing
• Major non-medical services bids completed

81

46

Feb/22

Feb/23

Feb/24

Feb/25

R$ 11mm Revenue Synergies

46	1.2pp MLR gain
	0.4pp G&A gain

Feb/23

Feb'23 target already identified and scheduled

R$ 99mm

already reflected in 2022 results

(R$70mm in 3Q22)

3

ESG

Agenda Sustainability as a pillar of development

ENVIRONMENTAL

• NDI was recognized, for the second consecutive year, with the gold seal by the Brazilian GHG Protocol Program for its performance in the Greenhouse Gas Inventory for 2021
• We signed a contract with EDP for the production of clean energy for 85% NDI's units over the next 15 years. The photovoltaic plant is the result of a co-investment between EDP Renováveis and EDP Brasil. The transaction awaits approval from the Board of Directors for Economic Defense (CADE)

GOAL: CARBON NEUTRAL IN 2023!

• GHG Inventory to be completed in 2022
• Purchase of carbon credits in 2013 to neutralize emissions

SOCIAL

• We joined (i) the Business and LGBTQIA+ Rights Forum, (ii) the
  Business Coalition for the End of Violence against Girls and Women and (iii) REIS - Business Network for Social Inclusion
• We launched (i) the Women's Channel with the NGO JUSTICEIRAS, offering psychological, legal and social support to our female employees; (ii) the Diversity Manifest and (iii) the ONE Program in partnership with Oracle for training PwD in the IT market

4

Net

Revenues Increase in the beneficiary base driven by Health Plans

		Net Revenues (R$mm)
	19,228.2		22,467.7	5,779.5	6,321.2
14,046.8	10,673.3		12,584.4	3,220.7	3,716.5
8,412.4
5,634.4	8,555.0		9,883.4	2,558.9	2,604.7
2019	2020		2021	3Q21	3Q22
Health Plans(1)	Dental Plans(1)	Hospital Services(1)(2)
5,474.2	6,038.7	182.1	201.0	376.4	386.2
2,961.8	3,472.7
2,512.4	2,566.0
3Q21	3Q22	3Q21	3Q22	3Q21	3Q22

1. Gross Revenues
2. Includes revenues from other services, patient transportation services (ambulances) and occupational health

NET REVENUES: +9.4% vs. 3Q21

HEALTH PLANS: +10.3% vs. 3Q21

Avg. Beneficiaries: +6.2%

• +344k Organic
• +175k M&A Avg. Ticket: +3.9%
• +5.2% price readjustment and mix
• -1.0% individual negative readjustment
• -0.3% impacted by lower avg. ticket from recent acquisitions

DENTAL PLANS: +10.4% vs. 3Q21

Avg. Beneficiaries: +10.8%; +665k Organic

Avg. Ticket: -0.4%; result of the loyalty and cross-selling strategy

HOSPITAL SERVICES: +2.6% vs. 3Q21

5